WHO Releases Disease-Agnostic Contact Tracing Guideline
The clinical practice guideline establishes definitions and strategies for improving contact tracing, addressing gaps revealed during the COVID-19 pandemic and other outbreaks.
The clinical practice guideline establishes definitions and strategies for improving contact tracing, addressing gaps revealed during the COVID-19 pandemic and other outbreaks.
The clinical practice guideline establishes definitions and strategies for improving contact tracing, addressing gaps revealed during the COVID-19 pandemic and other outbreaks.
Read MoreThe latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read MoreThe American Heart Association and the American Red Cross have issued the 2024 first aid guidelines, the first major update since 2010.
Read MoreFor most critically ill patients, the guideline strongly recommends a restrictive approach to red blood cell transfusion to mitigate risks while promoting judicious use of blood cells.
Read MoreThe guideline provides nine evidence-based recommendations to standardize the collection, processing, and handling of specimens for improved lung cancer diagnosis and staging.
Read MoreFuture updates to COVID-19 treatment recommendations will transition to professional medical societies.
Read MoreThe guideline offers 12 evidence-based recommendations to improve the management of both malignant and nonmalignant central airway obstruction.
Read MoreExperts are invited to help the WHO develop updated global guidelines for the effective diagnosis and management of asthma and COPD.
Read MoreThe new guidelines recommend a combination of behavioral support, digital cessation tools, and pharmacological treatments to aid tobacco cessation in adults.
Read MoreThe CDC’s updated guidance recommends vaccination only for high-risk adults aged 60-74, while strengthening its advice for adults 75 and older.
Read MoreDespite updated guidelines, only 14.5% of adults with moderate to severe asthma are prescribed the SMART combination inhaler regimen.Â
Read MoreThe COPD Foundation Nebulizer Consortium’s statement provides recommendations for preventing the spread of respiratory illnesses in healthcare settings and home environments. Â
Read MoreResearchers have crafted the first-ever guidelines to standardize the preparation process for families considering oral immunotherapy.
Read MoreThe guideline provides 12 evidence-based key action statements to guide clinicians in treating patients experiencing symptoms from inhalant allergies.Â
Read MoreThe Phoenix criteria define sepsis as severe response to infection involving organ dysfunction, as opposed to an earlier focus on systemic inflammation.
Read MoreTwo practice parameters from the Joint Task Force for Practice Parameters offer evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis in pediatric and adult patients.Â
Read MoreA new ATS clinical practice guideline recommends expanding antifibrotic treatment to all patients with systemic sclerosis associated with ILD, not just those with progressive disease.
Read MoreNearly 5 million US adults who smoke and formerly smoked are now recommended for testing.
Read MoreThe Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the diagnosis and treatment of patients living with pulmonary hypertension related to interstitial lung disease.
Read MoreSevere asthma patients account for as much as 60% of all asthma healthcare costs, and proper management of severe disease is essential.
Read MoreACP issued four practice points on the pharmacologic and biologic treatment of COVID-19 in the outpatient setting, endorsing two drugs and advising against two others.
Read MoreThe latest guideline from the American Thoracic Society reaffirms benefits for patients with COPD as well as pulmonary hypertension and interstitial lung disease.
Read MoreThe document provides expert, opinion-based clinical practice guidance, along with test instructions, for a selection of commonly used tests which have documented clinimetric properties for people with cystic fibrosis.
Read MoreA modeling study suggests that continuing anticoagulation therapy indefinitely, which is recommended in all patients with a first unprovoked venous thromboembolism, has little chance of improving life expectancy and is unlikely to ever be cost-effective.Â
Read More